The G6PD deficiency increases hemoglobin vulnerability to oxidative damage, leading to hemoglobin instability and precipitation of Heinz bodies. [1] G6PD deficiency is the most common red cell enzyme abnormality associated with hemolysis. It is also known to be associated with neonatal jaundice, kernicterus, and even death. The marked elevation of bilirubin levels that sometimes occurs in the neonatal period raises the risk of kernicterus. Neonatal hyperbilirubinemia often arises in association with Gilbert's syndrome. [2, 3] It affects over 400 million people worldwide. [4] G6PD deficiency occurs with increased frequency throughout Africa, Asia, the Mediterranean, and the Middle East. In the United States, black males are most commonly affected, with a prevalence of approximately 10%. [5] The global distribution and health burden of G6PD deficiency has Background: Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme essential for basic cellular functions, including protection of red cell proteins from oxidative damage. G6PD deficiency is the most common red cell enzyme abnormality associated with hemolysis as well as with neonatal jaundice, kernicterus, and even death. It plays a protective role against malaria. It is a genetically inherited sex-linked abnormality.
Objectives:
To determine the age, sex, and different community-wise incidence of G6PD deficiency in neonatal subjects having neonatal hyperbilirubinemia.
Introduction
Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme essential for basic cellular functions, including protection of red cell proteins from oxidative damage. been reviewed by the World Health Organization (WHO). [4] About 7.5% of the world's population carries a gene for G6PD deficiency, the proportion ranging from a maximum of 35% in parts of Africa to 0.1% in Japan and parts of Europe. The distribution of populations with high frequency of G6PD deficiency geographically overlaps closely with the prevalence of malaria, suggesting that G6PD deficiency may play a protective role against malaria. [6] G6PD is a housekeeping gene expressed in all the tissues. Due to its extreme importance in red blood cells, mutants showing 100% deficiency of the G6PD enzyme will be incompatible with life and are thus not reported. Indeed gross deletion, nonsense mutations, frame-shift mutations, and splicing defects are not reported for this gene. [7, 8] Using biochemical methods, 442 variants of G6PD enzyme have been identified. Of these, 299 were characterized by methods agreed on by the WHO.
[4] The G6PD variants have been divided into five classes by the WHO according to their activity in the red cell. G6PD deficiency is genetically inherited sex-linked abnormality. The gene encoding G6PD located on the X-chromosome, (Xq28), is over 20 Kb in length and contains 13 exons. [9] Being sex-linked condition, the prevalence of G6PD deficiency in any given population is determined by the number of deficient males. [10] However, deficient females are also at risk of hemolysis and jaundice.
Materials and Methods
In this study, total 170 neonates having hyperbilirubinemia were selected. Informed consent was obtained from all subjects. Approval from ethics committee of the institution was taken before commencing the study. After taking consent from each patient, 5 ml blood was withdrawn from each of the neonate by aseptic method in K3 EDTA vacutainer. The duration of this study was between August 2007 and July 2009 at B.J. Medical College & Civil Hospital, Ahmedabad, Gujarat, India.
All these samples were checked for G6PD activity by methemoglobin reduction test. After completing these procedures, all samples were interpreted as G6PD present, which show clear red color, and as G6PD deficient, which show brown color. All the samples showing G6PD deficiency were retested by repeating the same method.
Results
In this study, total 170 neonates having hyperbilirubinemia were selected at B.J. Medical College & Civil Hospital during period of 2 years between August 2007 and July 2009. Of 170 neonates, 123 (72.4%) were males and 47 (27.6%) were females. Of 170 neonates, 18 (10.6%) neonates showed deficiency of G6PD in red cells. Total incidence of G6PD enzyme deficiency was found to be 10.6%. Male neonates showed having higher incidence of 12.2% compared to females having an incidence of 6.4%. Among these 170 subjects, 118 (69.4%) belonged to Hindu community and 28 (16.5%) to Muslim community. Among these 18 G6PD enzyme-deficient subjects, 11 (61.1%) were of Hindu and 4 (22.2%) were of Muslim communities. Among all these communities, Parsi community had highest incidence (33.3%) of G6PD enzyme deficiency followed by Sindhi community (16.7%), mostly because of smaller sample size. Muslim community had higher incidence (14.3%) than Hindu (9.3%) community because of consanguineous marriages. No deficient neonates were found among Rajput, Marathi, and Sikh communities. Overall incidence was found to be higher than general in neonates of Parsi, Sindhi, and Muslim communities, whereas it was lower than general in neonates belonging to Marwadi and Hindu communities. Sex-wise distribution showed highest incidence rate of 50.0% among Parsi male neonates, followed by Muslim and Sindhi neonates having same incidence rate of 16.7%, which is higher than general incidence rate (6.4%).
Among total 170 subjects, 39 (22.9%) were early neonates (aged up to 7 days) and 131 (77.1%) were late neonates (aged 8 to 28 days). Among these 39 early neonates, 17 (43.6%) were 6-day old, 9 (23.1%) were 5-day old, and 6 (15.4%) were 4-day old. Among total 18 G6PD enzymedeficient subjects, 11 (61.1%) were early neonates and 7 (38.9%) were late neonates. Among these 11 G6PD enzyme-deficient early neonates, 5 (45.5%) were 6-day old, 3 (27.3%) were 5-day old, and 2 (18.2%) were 2-day old.
Discussion
In this study, total incidence of G6PD enzyme deficiency is 10.6%. Male neonates were found to have higher incidence of 12.2% compared to females having an incidence of 6.4%. Among these 18 G6PD enzyme-deficient subjects, 61.1% were from Hindu and 22.2% were from Muslim communities. Among total 18 G6PD enzyme-deficient subjects, 61.1% were early neonates and 38.9% were late neonates. Among these 11 G6PD enzyme-deficient early neonates, 45.5% were 6-day old, 27.3% were 5-day old, and 18.2% were 2-day old.
In the study of Gupte et al. [11] , of total 1644 subjects, 359 (21.8%) were having G6PD enzyme deficiency. In the study of Pao et al. [12] , of total 2479 subjects, 50 (2.0%) were having G6PD enzyme deficiency. In the study of Kuruvilla et al. [13] , of total 212 subjects, 25 (11.8%) were having G6PD enzyme deficiency. In this study, total incidence of G6PD enzyme deficiency was found to be 10.6%, which is closely similar with the findings of the study by Kuruvilla et al., [13] higher than the study by Pao et al., [12] and lower than the study by Gupte et al. [11] G6PD is an X-linked condition and males are therefore more commonly and more severely affected than females. Neonatal jaundice is the most common clinical presentation. So in a population with a high prevalence rate, early detection of G6PD enzyme deficiency by neonatal screening is desirable to take appropriate measures to prevent the complications of hemolysis and jaundice.
Conclusion
The G6PD-deficient neonates are prone to a greater incidence of neonatal jaundice. Methylene blue reduction test is useful screening procedure, so the quantitative enzyme assay must be used for a definitive diagnosis of G6PD deficiency. Highest incidence of G6PD deficiency was found in Parsi community because of smaller sample size followed by Sindhi, Muslim, and Marwadi communities. No deficient neonate was found among Rajput, Marathi, and Sikh communities. Sex-wise distribution among all different communities showed highest incidence rate among male neonates than among their female counterparts. Highest incidence rate of G6PD deficiency was found to be among 2-day-old neonates.
In a population with a high prevalence rate, early detection of G6PD enzyme deficiency by neonatal screening is desirable to take appropriate measures to prevent the complications of hemolysis and jaundice.
